chr19-22664356-G-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_020855.3(ZNF492):c.687G>C(p.Glu229Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000373 in 1,393,838 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020855.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ZNF492 | NM_020855.3 | c.687G>C | p.Glu229Asp | missense_variant | Exon 4 of 4 | ENST00000456783.3 | NP_065906.1 | |
| ZNF492 | XM_047439130.1 | c.687G>C | p.Glu229Asp | missense_variant | Exon 4 of 4 | XP_047295086.1 | ||
| ZNF492 | XM_047439131.1 | c.591G>C | p.Glu197Asp | missense_variant | Exon 3 of 3 | XP_047295087.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000338 AC: 5AN: 147946Hom.: 0 Cov.: 28 show subpopulations
GnomAD2 exomes AF: 0.0000760 AC: 8AN: 105262 AF XY: 0.000128 show subpopulations
GnomAD4 exome AF: 0.0000373 AC: 52AN: 1393838Hom.: 1 Cov.: 31 AF XY: 0.0000465 AC XY: 32AN XY: 688142 show subpopulations
Age Distribution
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000338 AC: 5AN: 148072Hom.: 0 Cov.: 28 AF XY: 0.0000415 AC XY: 3AN XY: 72226 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.687G>C (p.E229D) alteration is located in exon 4 (coding exon 3) of the ZNF492 gene. This alteration results from a G to C substitution at nucleotide position 687, causing the glutamic acid (E) at amino acid position 229 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at